Aarti Pharmalabs Ltd Q2FY25; 6% rise in Profits

Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals

Financial Results:

Aarti Pharmalabs Ltd reported Revenues for Q2FY25 of ₹458.00 Crores up from ₹440.00 Crore year on year, a rise of 4.09%.

Total Expenses for Q2FY25 of ₹391.00 Crores up from ₹374.00 Crores year on year, a rise of 4.55%.

Consolidated Net Profit of ₹55.00 Crores up 5.77% from ₹52.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹6.03, up 5.42% from ₹5.72 in the same quarter of the previous year.